In severe eosinophilic asthma controlled with benralizumab, tapering high-dose ICS reduced dose while maintaining control. Stanbrook MB. Ann Intern Med 2024 Apr 2. doi: 10.7326/J24-0014.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stanbrook MB. In severe eosinophilic asthma controlled with benralizumab, tapering high-dose ICS reduced dose while maintaining control. Ann Intern Med 2024 Apr 2. doi: 10.7326/J24-0014.
PMID: 38560905